Pages that link to "Q36400485"
Jump to navigation
Jump to search
The following pages link to Targeting melanocortin receptors as potential novel therapeutics (Q36400485):
Displaying 50 items.
- The role of proopiomelanocortin (POMC) neurones in feeding behaviour (Q21245071) (← links)
- Adrenocorticotropic hormone for acute gout (Q24241485) (← links)
- The melanocortin MC(1) receptor agonist BMS-470539 inhibits leucocyte trafficking in the inflamed vasculature (Q24632057) (← links)
- Neuroprotective Effects Against POCD by Photobiomodulation: Evidence from Assembly/Disassembly of the Cytoskeleton (Q26768713) (← links)
- Unraveling the genetics of human obesity (Q33267907) (← links)
- Solid-phase peptide head-to-side chain cyclodimerization: Discovery of C2-symmetric cyclic lactam hybrid α-melanocyte-stimulating hormone (MSH)/agouti-signaling protein (ASIP) analogues with potent activities at the human melanocortin receptors (Q34583185) (← links)
- Neuroanatomical distribution of the melanocortin-4 receptors in male and female rodent brain (Q34660287) (← links)
- Homeostastic and non-homeostatic functions of melanocortin-3 receptors in the control of energy balance and metabolism (Q35115954) (← links)
- Repository corticotropin injection in a patient presenting with focal segmental glomerulosclerosis, rheumatoid arthritis, and optic neuritis: a case report (Q35219562) (← links)
- Sex, social status and physiological stress in primates: the importance of social and glucocorticoid dynamics (Q35540322) (← links)
- Genetic dissection of the functions of the melanocortin-3 receptor, a seven-transmembrane G-protein-coupled receptor, suggests roles for central and peripheral receptors in energy homeostasis. (Q35562552) (← links)
- α-Melanocyte-stimulating-hormone (α-MSH) modulates human chondrocyte activation induced by proinflammatory cytokines. (Q35669556) (← links)
- Host phenotype characteristics and MC1R in relation to early-onset basal cell carcinoma (Q35834723) (← links)
- The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. (Q36003378) (← links)
- New targets to treat obesity and the metabolic syndrome (Q36068914) (← links)
- Selected melanocortin 1 receptor single-nucleotide polymorphisms differentially alter multiple signaling pathways (Q36105389) (← links)
- Systematic Backbone Conformational Constraints on a Cyclic Melanotropin Ligand Leads to Highly Selective Ligands for Multiple Melanocortin Receptors (Q36128120) (← links)
- Recent understanding of IBD pathogenesis: implications for future therapies (Q36639759) (← links)
- PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation (Q36727430) (← links)
- Recent developments in crystal-induced inflammation pathogenesis and management. (Q36832546) (← links)
- Adrenocorticotropic hormone gel in the treatment of systemic lupus erythematosus: A retrospective study of patients (Q36851414) (← links)
- Obesity-related genetic variants, human pigmentation, and risk of melanoma (Q36931200) (← links)
- Melanocyte receptors: clinical implications and therapeutic relevance. (Q36954814) (← links)
- Centrally acting mechanisms for the treatment of male sexual dysfunction (Q36993652) (← links)
- A novel role for pigment genes in the stress response in rainbow trout (Oncorhynchus mykiss) (Q37061557) (← links)
- Overview of the management of acute gout and the role of adrenocorticotropic hormone (Q37101535) (← links)
- Management of gout (Q37139512) (← links)
- Melanocortin peptides inhibit urate crystal-induced activation of phagocytic cells (Q37453876) (← links)
- Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis (Q37599583) (← links)
- Melanocortin Control of Cell Trafficking in Vascular Inflammation (Q37827459) (← links)
- Equine Pituitary Pars Intermedia Dysfunction (Q37851669) (← links)
- Melanocortins as potential therapeutic agents in severe hypoxic conditions (Q38005251) (← links)
- The melanocortin-4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic options (Q38115094) (← links)
- Generation of a human bone marrow-derived mesenchymal stem cell line expressing and secreting high levels of bioactive α-melanocyte-stimulating hormone (Q39206342) (← links)
- LRP6 Mediates cAMP Generation by G Protein–Coupled Receptors Through Regulating the Membrane Targeting of Gα s (Q39575659) (← links)
- A retro‐inverso α‐melanocyte stimulating hormone analog with MC1R‐binding selectivity (Q39618048) (← links)
- Alpha-MSH regulates intergenic splicing of MC1R and TUBB3 in human melanocytes (Q39632902) (← links)
- Enhanced Cationic Charge is a Key Factor in Promoting Staphylocidal Activity of α-Melanocyte Stimulating Hormone via Selective Lipid Affinity (Q40575180) (← links)
- Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of action (Q41144274) (← links)
- Melanocortins protect against multiple organ dysfunction syndrome in mice (Q42618304) (← links)
- Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage (Q42940207) (← links)
- Pharmacogenetics of opioid analgesics in dogs (Q43076078) (← links)
- Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion (Q43108153) (← links)
- The influence of alpha-, beta-, and gamma-melanocyte stimulating hormone on acetaminophen induced liver lesions in male CBA mice. (Q43119470) (← links)
- Effects of alpha-melanocortin enantiomers on acetaminophen-induced hepatotoxicity in CBA mice (Q43208750) (← links)
- Melanocortin 4 receptor stimulation decreases pancreatitis severity in rats by activation of the cholinergic anti-inflammatory pathway. (Q44874138) (← links)
- Structural Insights into Selective Ligand-Receptor Interactions Leading to Receptor Inactivation Utilizing Selective Melanocortin 3 Receptor Antagonists. (Q45063479) (← links)
- Vagus nerve mediates the protective effects of melanocortins against cerebral and systemic damage after ischemic stroke (Q46239172) (← links)
- Improved cutaneous wound healing after intraperitoneal injection of alpha-melanocyte-stimulating hormone. (Q47785648) (← links)
- Subcutaneous repository corticotropin gel for non-infectious panuveitis: Reappraisal of an old pharmacologic agent (Q50334146) (← links)